 Roberta Pelanda
Concepts (386)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 51 | 2023 | 770 | 8.050 |
Why?
| | Receptors, Antigen, B-Cell | 28 | 2023 | 101 | 5.340 |
Why?
| | Central Tolerance | 4 | 2022 | 8 | 2.960 |
Why?
| | Autoimmunity | 11 | 2022 | 831 | 2.940 |
Why?
| | Precursor Cells, B-Lymphoid | 6 | 2023 | 33 | 2.390 |
Why?
| | Cell Differentiation | 16 | 2022 | 1753 | 2.310 |
Why?
| | Autoantibodies | 11 | 2022 | 1335 | 1.760 |
Why?
| | Immune Tolerance | 8 | 2021 | 334 | 1.760 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2022 | 227 | 1.600 |
Why?
| | B-Lymphocyte Subsets | 6 | 2018 | 66 | 1.530 |
Why?
| | T-Lymphocytes | 11 | 2022 | 1774 | 1.380 |
Why?
| | Autoantigens | 7 | 2021 | 397 | 1.220 |
Why?
| | Mice | 62 | 2023 | 15520 | 1.090 |
Why?
| | Signal Transduction | 18 | 2023 | 4709 | 1.000 |
Why?
| | Animals | 71 | 2023 | 33381 | 0.930 |
Why?
| | Mice, Transgenic | 15 | 2021 | 2025 | 0.820 |
Why?
| | Immunoglobulin Light Chains | 7 | 2014 | 35 | 0.820 |
Why?
| | Mice, Inbred BALB C | 15 | 2021 | 1206 | 0.810 |
Why?
| | Mice, Knockout | 19 | 2022 | 2680 | 0.790 |
Why?
| | Receptors, CXCR4 | 1 | 2021 | 81 | 0.780 |
Why?
| | Antibody Formation | 5 | 2018 | 276 | 0.750 |
Why?
| | Models, Animal | 4 | 2019 | 363 | 0.740 |
Why?
| | Spleen | 8 | 2019 | 510 | 0.730 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 7 | 0.700 |
Why?
| | CD8-Positive T-Lymphocytes | 6 | 2023 | 702 | 0.690 |
Why?
| | Immune System | 3 | 2021 | 181 | 0.690 |
Why?
| | Bone Marrow Cells | 5 | 2022 | 273 | 0.660 |
Why?
| | B-Cell Activation Factor Receptor | 5 | 2018 | 13 | 0.620 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 3 | 2018 | 160 | 0.610 |
Why?
| | Mice, Inbred MRL lpr | 4 | 2022 | 39 | 0.600 |
Why?
| | Lysophospholipids | 4 | 2023 | 68 | 0.590 |
Why?
| | Antigens, CD | 7 | 2015 | 460 | 0.590 |
Why?
| | MAP Kinase Signaling System | 1 | 2018 | 292 | 0.560 |
Why?
| | Flow Cytometry | 10 | 2022 | 1085 | 0.560 |
Why?
| | Lymphocyte Activation | 8 | 2022 | 1067 | 0.540 |
Why?
| | Cell Proliferation | 5 | 2020 | 2275 | 0.540 |
Why?
| | Bone Marrow | 5 | 2023 | 255 | 0.530 |
Why?
| | Receptors, Lysophosphatidic Acid | 6 | 2023 | 29 | 0.490 |
Why?
| | Immunoglobulin kappa-Chains | 6 | 2015 | 18 | 0.480 |
Why?
| | Gene Rearrangement, B-Lymphocyte | 4 | 2007 | 7 | 0.470 |
Why?
| | ras Proteins | 1 | 2014 | 141 | 0.460 |
Why?
| | Immunoglobulin M | 7 | 2023 | 253 | 0.450 |
Why?
| | Receptors, Cytokine | 1 | 2013 | 33 | 0.450 |
Why?
| | Tumor Virus Infections | 2 | 2012 | 41 | 0.440 |
Why?
| | Immunoglobulins | 3 | 2012 | 154 | 0.440 |
Why?
| | Glucocorticoid-Induced TNFR-Related Protein | 1 | 2012 | 5 | 0.430 |
Why?
| | Plasma Cells | 1 | 2012 | 59 | 0.430 |
Why?
| | Rhadinovirus | 1 | 2012 | 16 | 0.430 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Heavy Chain | 3 | 2002 | 11 | 0.420 |
Why?
| | Peripheral Tolerance | 3 | 2022 | 14 | 0.410 |
Why?
| | Guanine Nucleotide Exchange Factors | 5 | 2011 | 59 | 0.410 |
Why?
| | Interleukin Receptor Common gamma Subunit | 1 | 2011 | 15 | 0.400 |
Why?
| | Immunologic Memory | 2 | 2013 | 313 | 0.400 |
Why?
| | Transplantation Chimera | 1 | 2011 | 51 | 0.390 |
Why?
| | Immunoglobulin Heavy Chains | 7 | 2013 | 72 | 0.390 |
Why?
| | Lymph Nodes | 2 | 2013 | 455 | 0.380 |
Why?
| | Herpesviridae Infections | 1 | 2012 | 142 | 0.380 |
Why?
| | Mice, Inbred C57BL | 17 | 2021 | 4908 | 0.380 |
Why?
| | Cytokines | 4 | 2023 | 1900 | 0.380 |
Why?
| | Genetic Variation | 1 | 2015 | 926 | 0.380 |
Why?
| | Genes, Immunoglobulin | 5 | 2000 | 26 | 0.370 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2023 | 341 | 0.330 |
Why?
| | Immunity, Humoral | 3 | 2014 | 117 | 0.330 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2021 | 540 | 0.320 |
Why?
| | Disease Models, Animal | 10 | 2022 | 3730 | 0.310 |
Why?
| | Immunoglobulin Allotypes | 1 | 2007 | 6 | 0.310 |
Why?
| | DNA-Binding Proteins | 5 | 2011 | 1346 | 0.310 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2020 | 164 | 0.300 |
Why?
| | Immunoglobulin Variable Region | 6 | 2007 | 71 | 0.300 |
Why?
| | Antigens, CD19 | 4 | 2015 | 96 | 0.290 |
Why?
| | Gene Expression Regulation | 5 | 2018 | 2445 | 0.290 |
Why?
| | Transgenes | 2 | 2018 | 174 | 0.290 |
Why?
| | Immunoglobulin Joining Region | 4 | 2002 | 10 | 0.280 |
Why?
| | Integrases | 3 | 2006 | 123 | 0.280 |
Why?
| | RNA Editing | 1 | 2005 | 22 | 0.270 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2018 | 827 | 0.270 |
Why?
| | Antibodies, Neutralizing | 3 | 2020 | 228 | 0.270 |
Why?
| | Immunoglobulin Isotypes | 2 | 2022 | 32 | 0.270 |
Why?
| | Humans | 33 | 2023 | 118974 | 0.270 |
Why?
| | Antigens | 3 | 2013 | 320 | 0.260 |
Why?
| | Hybridomas | 3 | 2012 | 233 | 0.250 |
Why?
| | Proto-Oncogene Proteins | 4 | 2010 | 618 | 0.240 |
Why?
| | Cell Separation | 4 | 2018 | 296 | 0.240 |
Why?
| | Cells, Cultured | 8 | 2019 | 4077 | 0.240 |
Why?
| | Neoplasms | 3 | 2022 | 2179 | 0.240 |
Why?
| | Tumor Microenvironment | 3 | 2022 | 454 | 0.230 |
Why?
| | Biliary Atresia | 2 | 2018 | 224 | 0.230 |
Why?
| | HIV-1 | 2 | 2020 | 776 | 0.230 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2023 | 27 | 0.220 |
Why?
| | CD79 Antigens | 4 | 2018 | 14 | 0.220 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 112 | 0.220 |
Why?
| | Enzyme Activation | 2 | 2018 | 828 | 0.220 |
Why?
| | Carcinogenesis | 3 | 2019 | 182 | 0.210 |
Why?
| | Immunological Synapses | 1 | 2022 | 18 | 0.210 |
Why?
| | Models, Immunological | 3 | 2018 | 94 | 0.210 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 367 | 0.210 |
Why?
| | Homeostasis | 2 | 2018 | 594 | 0.200 |
Why?
| | Immunoglobulin G | 3 | 2018 | 788 | 0.190 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2023 | 1171 | 0.190 |
Why?
| | Heterografts | 1 | 2021 | 130 | 0.190 |
Why?
| | Female | 11 | 2022 | 61565 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2023 | 420 | 0.190 |
Why?
| | Immunotherapy | 2 | 2022 | 493 | 0.190 |
Why?
| | Mice, Mutant Strains | 3 | 2012 | 280 | 0.190 |
Why?
| | Adaptive Immunity | 2 | 2018 | 161 | 0.190 |
Why?
| | Quinoxalines | 1 | 2020 | 62 | 0.190 |
Why?
| | Cell Membrane | 1 | 2004 | 710 | 0.190 |
Why?
| | Male | 9 | 2022 | 57801 | 0.180 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 76 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 394 | 0.180 |
Why?
| | Immunoglobulin lambda-Chains | 2 | 2015 | 6 | 0.180 |
Why?
| | Viral Proteins | 1 | 2002 | 296 | 0.180 |
Why?
| | Cell Survival | 4 | 2018 | 1047 | 0.170 |
Why?
| | Age Factors | 3 | 2013 | 2995 | 0.170 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 177 | 0.170 |
Why?
| | beta Catenin | 1 | 2020 | 219 | 0.170 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2019 | 158 | 0.170 |
Why?
| | Immunity, Innate | 2 | 2018 | 745 | 0.160 |
Why?
| | Lymphopoiesis | 1 | 2018 | 23 | 0.160 |
Why?
| | Stem Cells | 2 | 2002 | 559 | 0.160 |
Why?
| | Xenograft Model Antitumor Assays | 4 | 2022 | 740 | 0.160 |
Why?
| | Piperazines | 1 | 2020 | 316 | 0.160 |
Why?
| | Receptors, Complement 3d | 1 | 2019 | 129 | 0.160 |
Why?
| | Retroviridae | 1 | 2018 | 89 | 0.160 |
Why?
| | Herpesvirus 4, Human | 1 | 2018 | 126 | 0.160 |
Why?
| | Bile Ducts | 1 | 2018 | 73 | 0.160 |
Why?
| | Transduction, Genetic | 1 | 2018 | 116 | 0.160 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2018 | 73 | 0.150 |
Why?
| | Antibodies | 3 | 2015 | 392 | 0.150 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 94 | 0.150 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2019 | 200 | 0.150 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 197 | 0.150 |
Why?
| | Membrane Glycoproteins | 2 | 2015 | 446 | 0.150 |
Why?
| | Genetic Vectors | 1 | 2018 | 302 | 0.150 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2019 | 156 | 0.150 |
Why?
| | Allergens | 1 | 2020 | 424 | 0.140 |
Why?
| | Interleukins | 1 | 2018 | 242 | 0.140 |
Why?
| | HIV Infections | 3 | 2020 | 2459 | 0.140 |
Why?
| | B-Cell Activating Factor | 2 | 2018 | 18 | 0.140 |
Why?
| | Phenotype | 2 | 2021 | 3003 | 0.140 |
Why?
| | Alleles | 4 | 2007 | 832 | 0.140 |
Why?
| | Genes, bcl-2 | 2 | 2018 | 20 | 0.130 |
Why?
| | Histones | 1 | 2020 | 552 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2019 | 632 | 0.130 |
Why?
| | Receptors, Lysosphingolipid | 3 | 2010 | 13 | 0.130 |
Why?
| | Antibody Affinity | 2 | 2012 | 55 | 0.130 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2020 | 1167 | 0.130 |
Why?
| | Heart Transplantation | 1 | 2021 | 671 | 0.130 |
Why?
| | VDJ Recombinases | 3 | 2004 | 4 | 0.130 |
Why?
| | Immunophenotyping | 1 | 2015 | 278 | 0.130 |
Why?
| | Graft Rejection | 2 | 2021 | 555 | 0.130 |
Why?
| | Macrophages, Peritoneal | 2 | 2011 | 96 | 0.120 |
Why?
| | Fibronectins | 2 | 2011 | 114 | 0.120 |
Why?
| | Toll-Like Receptors | 2 | 2020 | 167 | 0.120 |
Why?
| | Adoptive Transfer | 2 | 2013 | 204 | 0.120 |
Why?
| | Rotavirus | 1 | 2013 | 26 | 0.120 |
Why?
| | Animals, Newborn | 2 | 2018 | 806 | 0.120 |
Why?
| | Gene Targeting | 2 | 2006 | 80 | 0.120 |
Why?
| | Azospirillum brasilense | 1 | 1993 | 1 | 0.120 |
Why?
| | Glutamate Synthase | 1 | 1993 | 2 | 0.120 |
Why?
| | Antibody Diversity | 3 | 2007 | 17 | 0.110 |
Why?
| | Clonal Selection, Antigen-Mediated | 1 | 2012 | 3 | 0.110 |
Why?
| | Lymphocyte Count | 1 | 2013 | 136 | 0.110 |
Why?
| | HIV Antibodies | 1 | 2013 | 50 | 0.110 |
Why?
| | Kinetics | 3 | 2012 | 1624 | 0.110 |
Why?
| | Toll-Like Receptor 7 | 1 | 2012 | 35 | 0.110 |
Why?
| | Genes, Bacterial | 1 | 1993 | 162 | 0.110 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 119 | 0.110 |
Why?
| | fas Receptor | 1 | 2012 | 98 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 404 | 0.110 |
Why?
| | Rho Guanine Nucleotide Exchange Factors | 5 | 2011 | 19 | 0.110 |
Why?
| | Receptors, Thromboxane | 1 | 2011 | 6 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 628 | 0.110 |
Why?
| | Immunoglobulin mu-Chains | 2 | 2004 | 7 | 0.100 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 1974 | 0.100 |
Why?
| | Lupus Nephritis | 1 | 2012 | 55 | 0.100 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 415 | 0.100 |
Why?
| | Mice, Inbred NOD | 3 | 2022 | 574 | 0.100 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2015 | 407 | 0.100 |
Why?
| | Hematopoietic Stem Cells | 3 | 2011 | 359 | 0.100 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 127 | 0.100 |
Why?
| | Cell Communication | 1 | 2013 | 281 | 0.100 |
Why?
| | Dendritic Cells | 2 | 2012 | 442 | 0.100 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1390 | 0.100 |
Why?
| | Reperfusion Injury | 1 | 2013 | 276 | 0.090 |
Why?
| | Friend murine leukemia virus | 1 | 2010 | 30 | 0.090 |
Why?
| | Cholestasis | 1 | 2013 | 228 | 0.090 |
Why?
| | Cytidine Deaminase | 1 | 2010 | 57 | 0.090 |
Why?
| | Integrin alpha5beta1 | 1 | 2010 | 9 | 0.090 |
Why?
| | Self Tolerance | 1 | 2010 | 28 | 0.090 |
Why?
| | Proprotein Convertases | 1 | 2010 | 14 | 0.090 |
Why?
| | Integrins | 2 | 2007 | 82 | 0.090 |
Why?
| | Infant, Newborn | 1 | 2021 | 5255 | 0.090 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2010 | 133 | 0.090 |
Why?
| | Serine Endopeptidases | 1 | 2010 | 105 | 0.090 |
Why?
| | Immunity | 1 | 2010 | 129 | 0.090 |
Why?
| | Matrix Metalloproteinases | 1 | 2010 | 90 | 0.090 |
Why?
| | Immunity, Active | 1 | 2008 | 10 | 0.090 |
Why?
| | Interleukin-6 | 2 | 2023 | 688 | 0.080 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 398 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 191 | 0.080 |
Why?
| | Kidney Diseases | 1 | 2013 | 439 | 0.080 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Light Chain | 2 | 1998 | 4 | 0.080 |
Why?
| | Macrophages, Alveolar | 1 | 2011 | 359 | 0.080 |
Why?
| | Molecular Sequence Data | 4 | 2013 | 2871 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 770 | 0.080 |
Why?
| | Virus Replication | 1 | 2010 | 405 | 0.080 |
Why?
| | Mice, Nude | 2 | 2020 | 663 | 0.080 |
Why?
| | Recombination, Genetic | 4 | 2006 | 173 | 0.080 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2007 | 18 | 0.080 |
Why?
| | YY1 Transcription Factor | 1 | 2007 | 27 | 0.080 |
Why?
| | Melanoma | 1 | 2013 | 664 | 0.070 |
Why?
| | Bronchial Hyperreactivity | 1 | 2007 | 95 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2013 | 585 | 0.070 |
Why?
| | Cell Line | 3 | 2020 | 2707 | 0.070 |
Why?
| | I-kappa B Kinase | 1 | 2006 | 50 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2019 | 2851 | 0.070 |
Why?
| | Th2 Cells | 1 | 2007 | 164 | 0.070 |
Why?
| | Binding Sites, Antibody | 1 | 2005 | 38 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2006 | 147 | 0.070 |
Why?
| | Kidney | 1 | 2013 | 1353 | 0.070 |
Why?
| | Rats | 1 | 2014 | 5392 | 0.070 |
Why?
| | Lymphoma, B-Cell | 1 | 2006 | 85 | 0.070 |
Why?
| | HIV Envelope Protein gp120 | 2 | 2017 | 60 | 0.070 |
Why?
| | DNA Nucleotidyltransferases | 2 | 2002 | 11 | 0.060 |
Why?
| | Immunoglobulin Class Switching | 2 | 2010 | 15 | 0.060 |
Why?
| | src-Family Kinases | 1 | 2005 | 90 | 0.060 |
Why?
| | Cell Movement | 2 | 2008 | 896 | 0.060 |
Why?
| | Clonal Deletion | 1 | 2004 | 18 | 0.060 |
Why?
| | Cell Division | 2 | 2004 | 776 | 0.060 |
Why?
| | Base Sequence | 3 | 2004 | 2159 | 0.060 |
Why?
| | Oligodeoxyribonucleotides | 2 | 2015 | 139 | 0.060 |
Why?
| | Monitoring, Immunologic | 1 | 2023 | 22 | 0.060 |
Why?
| | Mutagenesis | 1 | 2004 | 176 | 0.060 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 1999 | 814 | 0.060 |
Why?
| | Hematopoiesis | 1 | 2004 | 175 | 0.060 |
Why?
| | Immunoglobulin D | 1 | 2022 | 28 | 0.060 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 2 | 2014 | 83 | 0.050 |
Why?
| | Lectins, C-Type | 2 | 2014 | 63 | 0.050 |
Why?
| | Transplantation, Heterologous | 1 | 2022 | 194 | 0.050 |
Why?
| | Crosses, Genetic | 1 | 2002 | 138 | 0.050 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2022 | 26 | 0.050 |
Why?
| | NF-kappa B | 1 | 2006 | 670 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2013 | 372 | 0.050 |
Why?
| | Interferons | 1 | 2022 | 151 | 0.050 |
Why?
| | Leukosialin | 2 | 1999 | 15 | 0.050 |
Why?
| | Pneumonia | 1 | 2007 | 592 | 0.050 |
Why?
| | Inflammation | 2 | 2022 | 2566 | 0.050 |
Why?
| | Chimerism | 1 | 2021 | 28 | 0.050 |
Why?
| | Phosphorylation | 1 | 2005 | 1633 | 0.050 |
Why?
| | Lymphoid Tissue | 1 | 2021 | 65 | 0.050 |
Why?
| | Lymphocyte Subsets | 1 | 2021 | 76 | 0.050 |
Why?
| | Sialoglycoproteins | 2 | 1999 | 162 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2022 | 181 | 0.050 |
Why?
| | Hemagglutination | 1 | 2020 | 7 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 982 | 0.050 |
Why?
| | Mice, SCID | 1 | 2021 | 333 | 0.050 |
Why?
| | COS Cells | 1 | 2020 | 184 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2006 | 1055 | 0.050 |
Why?
| | Homozygote | 1 | 2000 | 190 | 0.050 |
Why?
| | RNA, Viral | 1 | 2023 | 572 | 0.050 |
Why?
| | Perforin | 1 | 2019 | 19 | 0.040 |
Why?
| | Heterozygote | 1 | 2000 | 262 | 0.040 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2019 | 45 | 0.040 |
Why?
| | Exocytosis | 1 | 2019 | 88 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 874 | 0.040 |
Why?
| | Viral Tropism | 1 | 2018 | 24 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2071 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2022 | 542 | 0.040 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2018 | 56 | 0.040 |
Why?
| | Antigens, Nuclear | 1 | 1998 | 18 | 0.040 |
Why?
| | Lipopolysaccharides | 2 | 2015 | 870 | 0.040 |
Why?
| | Virus Activation | 1 | 2018 | 80 | 0.040 |
Why?
| | Virus Latency | 1 | 2018 | 84 | 0.040 |
Why?
| | Mutagenesis, Insertional | 1 | 1997 | 61 | 0.040 |
Why?
| | Leukocyte Common Antigens | 1 | 1997 | 76 | 0.040 |
Why?
| | Immunization | 1 | 2020 | 412 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2020 | 965 | 0.040 |
Why?
| | Tamoxifen | 1 | 2018 | 198 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 300 | 0.040 |
Why?
| | Cross Reactions | 1 | 2017 | 116 | 0.040 |
Why?
| | Antibody Specificity | 2 | 2013 | 184 | 0.040 |
Why?
| | HIV | 1 | 2018 | 210 | 0.040 |
Why?
| | Lung | 1 | 2010 | 3664 | 0.040 |
Why?
| | DNA Helicases | 1 | 1998 | 131 | 0.040 |
Why?
| | Immunoglobulin Light Chains, Surrogate | 1 | 1996 | 1 | 0.040 |
Why?
| | Green Fluorescent Proteins | 2 | 2011 | 395 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 356 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 409 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1996 | 510 | 0.030 |
Why?
| | Syk Kinase | 1 | 2015 | 16 | 0.030 |
Why?
| | Cell Adhesion | 2 | 2007 | 443 | 0.030 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2015 | 36 | 0.030 |
Why?
| | Genes, Reporter | 2 | 2006 | 270 | 0.030 |
Why?
| | GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2014 | 5 | 0.030 |
Why?
| | B7-2 Antigen | 1 | 2014 | 25 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 80 | 0.030 |
Why?
| | Neoplastic Processes | 1 | 2013 | 4 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2015 | 215 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1691 | 0.030 |
Why?
| | Macrophages | 1 | 2021 | 1324 | 0.030 |
Why?
| | Immunologic Surveillance | 1 | 2013 | 19 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1284 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 1998 | 597 | 0.030 |
Why?
| | Chromosomes, Bacterial | 1 | 1993 | 7 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1993 | 76 | 0.030 |
Why?
| | Genes, Immunoglobulin Heavy Chain | 1 | 2013 | 9 | 0.030 |
Why?
| | Antigen-Presenting Cells | 1 | 2013 | 156 | 0.030 |
Why?
| | Operon | 1 | 1993 | 62 | 0.030 |
Why?
| | Calcium | 1 | 2019 | 1169 | 0.030 |
Why?
| | AIDS Vaccines | 1 | 2013 | 44 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 1993 | 201 | 0.030 |
Why?
| | Enzyme Induction | 1 | 2011 | 94 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1993 | 546 | 0.030 |
Why?
| | Autocrine Communication | 1 | 2011 | 42 | 0.030 |
Why?
| | Species Specificity | 1 | 2013 | 565 | 0.030 |
Why?
| | Apoptosis | 1 | 2020 | 2484 | 0.020 |
Why?
| | Ficoll | 1 | 2010 | 5 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 1999 | 989 | 0.020 |
Why?
| | Retroviridae Infections | 1 | 2010 | 46 | 0.020 |
Why?
| | Toll-Like Receptor 3 | 1 | 2010 | 31 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 359 | 0.020 |
Why?
| | Poly I-C | 1 | 2010 | 55 | 0.020 |
Why?
| | Receptors, IgG | 1 | 2010 | 67 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1816 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 305 | 0.020 |
Why?
| | DNA Methylation | 2 | 2007 | 503 | 0.020 |
Why?
| | Escherichia coli | 1 | 1993 | 758 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 290 | 0.020 |
Why?
| | Leukocytes | 1 | 2010 | 290 | 0.020 |
Why?
| | Cell Membrane Structures | 1 | 2007 | 5 | 0.020 |
Why?
| | Epitopes | 1 | 2010 | 443 | 0.020 |
Why?
| | RGS Proteins | 1 | 2007 | 12 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2010 | 526 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 567 | 0.020 |
Why?
| | Vaccines | 1 | 2013 | 380 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2007 | 116 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1435 | 0.020 |
Why?
| | PAX5 Transcription Factor | 1 | 2007 | 12 | 0.020 |
Why?
| | Molecular Weight | 1 | 2007 | 343 | 0.020 |
Why?
| | Gene Expression | 2 | 2006 | 1489 | 0.020 |
Why?
| | Bronchial Provocation Tests | 1 | 2007 | 54 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2010 | 613 | 0.020 |
Why?
| | Cell Polarity | 1 | 2007 | 133 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2007 | 136 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2010 | 683 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2006 | 13 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 207 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2006 | 27 | 0.020 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2006 | 20 | 0.020 |
Why?
| | Interleukin-7 | 1 | 2006 | 44 | 0.020 |
Why?
| | Protein Transport | 1 | 2007 | 412 | 0.020 |
Why?
| | Genetic Markers | 1 | 2007 | 348 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2007 | 310 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2006 | 113 | 0.020 |
Why?
| | Hyperplasia | 1 | 2006 | 170 | 0.020 |
Why?
| | Protein Kinase C-delta | 1 | 2006 | 69 | 0.020 |
Why?
| | Polymerase Chain Reaction | 2 | 1999 | 1012 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 823 | 0.020 |
Why?
| | Genotype | 1 | 2010 | 1882 | 0.020 |
Why?
| | Gene Deletion | 1 | 2006 | 361 | 0.020 |
Why?
| | DNA Nucleotidylexotransferase | 1 | 2004 | 11 | 0.020 |
Why?
| | Cell Lineage | 1 | 2006 | 318 | 0.020 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2004 | 7 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 9491 | 0.020 |
Why?
| | Embryonic and Fetal Development | 1 | 2004 | 95 | 0.020 |
Why?
| | Chromatin | 1 | 2007 | 441 | 0.010 |
Why?
| | RNA-Binding Proteins | 1 | 2006 | 371 | 0.010 |
Why?
| | Extracellular Matrix Proteins | 1 | 2004 | 133 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2004 | 174 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2006 | 580 | 0.010 |
Why?
| | Epigenesis, Genetic | 1 | 2007 | 539 | 0.010 |
Why?
| | DNA Primers | 1 | 2004 | 533 | 0.010 |
Why?
| | Down-Regulation | 1 | 2004 | 627 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 2004 | 468 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 18480 | 0.010 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 1999 | 15 | 0.010 |
Why?
| | Child | 1 | 2018 | 19129 | 0.010 |
Why?
| | Ku Autoantigen | 1 | 1998 | 12 | 0.010 |
Why?
| | Organ Specificity | 1 | 1999 | 278 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 1999 | 141 | 0.010 |
Why?
| | Genes, RAG-1 | 1 | 1997 | 12 | 0.010 |
Why?
| | Antigen Presentation | 1 | 1999 | 194 | 0.010 |
Why?
| | Germinal Center | 1 | 1997 | 47 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 1998 | 152 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1999 | 755 | 0.010 |
Why?
|
|
Pelanda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|